Skip to main content
STRATEC SE logo

STRATEC SE — Investor Relations & Filings

Ticker · SBS ISIN · DE000STRA555 LEI · 529900ZZJWANAFSPGV30 F Manufacturing
Open in API
Filings indexed 828 across all filing types
Latest filing 2006-06-30 Director's Dealing
Country DE Germany
Listing F SBS

About STRATEC SE

https://www.stratec.com/home

STRATEC SE is a global partner specializing in the design and manufacturing of fully automated solutions for OEM partners in the clinical diagnostics and life sciences industries. The company provides a comprehensive, integrated portfolio covering the entire value chain, from development and design to production and quality assurance. Its core offerings include fully automated analyzer systems (instrumentation), custom software and digital IoT solutions, and smart polymer-based consumables. Leveraging decades of experience and a broad technology base, STRATEC delivers tailored, high-quality systems that meet stringent regulatory standards, enabling its partners to bring advanced diagnostic and life science products to market.

Recent filings

Filing Released Lang Actions
Mitteilung uber Geschafte von Fuhrungspersonen nach 15a WpHG
Director's Dealing Classification · 1% confidence The document text explicitly contains the heading "Directors’ Dealings" and the German equivalent "Mitteilung über Geschäfte von Führungspersonen nach §15a WpHG" (Notification of transactions by persons discharging managerial responsibilities). It details a transaction (Verkauf/Sale) by an executive (Marcus Wolfinger, Geschäftsführendes Organ) involving company stock (Stammaktie) with ISIN DE0007289001. This directly matches the definition for Director's Dealing.
2006-06-30 German
STRATEC concludes major agreement for design of next generation instrumentation
Regulatory Filings Classification · 1% confidence The document is a short announcement (3311 characters) classified as 'Ad-hoc' and dated June 28, 2006. It details the conclusion of an exclusive agreement for developing instrumentation, including financial terms (up-front payment, development milestones) and strategic context. This type of announcement, which reports a significant business event (a major contract/partnership) rather than routine financial results (ER, IR) or mandatory regulatory filings (10-K, DEF 14A), fits best under general regulatory announcements or news releases. Since it is not a specific financial report, dividend notice, management change, or capital action, and it is a direct announcement of a business development, it falls under the general 'Regulatory Filings' (RNS) category, which serves as a broad category for significant, non-standard corporate news releases disseminated via services like DGAP.
2006-06-28 English
Q1 Report 2006
Interim / Quarterly Report Classification · 1% confidence The document is explicitly titled 'Interim Report as of March 31, 2006' and contains comprehensive financial statements, including a consolidated balance sheet and income statement for the first quarter of 2006. It provides detailed management commentary on business performance, acquisitions, and financial results. As it contains substantive financial data for a period shorter than a full fiscal year, it fits the definition of an Interim/Quarterly Report. Q1 2006
2006-05-17 English
3-Monatsbericht 2006
Interim / Quarterly Report Classification · 1% confidence The document is titled 'Zwischenbericht zum 31. März 2006' (Interim Report as of March 31, 2006) for STRATEC Biomedical Systems AG. It contains comprehensive financial statements, including a consolidated balance sheet, income statement, and cash flow statement for the first quarter of 2006. It provides detailed management commentary on business developments, acquisitions (Sanguin), and partnerships (CyBio). As it is a substantive financial report for a period shorter than a full fiscal year, it is classified as an Interim/Quarterly Report. Q1 2006
2006-05-17 German
Annual Report 2005
Annual Report Classification · 1% confidence The document is explicitly titled 'ANNUAL REPORT 2005' and contains comprehensive sections including the Report of the Board of Management, Consolidated Balance Sheet, Consolidated Income Statement, Notes to the Consolidated Financial Statements, and Audit Opinion. It covers the full fiscal year 2005 and provides detailed financial performance data, meeting the criteria for an Annual Report. FY 2005
2006-04-27 English
Jahresabschluß 2005
Annual Report Classification · 1% confidence The document is titled 'GESCHÄFTSBERICHT 2005' (Annual Report 2005) for STRATEC Biomedical Systems AG. It contains comprehensive financial statements, a management report (Konzernlagebericht), a report from the supervisory board (Bericht des Aufsichtsrats), and an auditor's report (Bestätigungsvermerk des Abschlussprüfers). It covers the full fiscal year 2005 and provides detailed financial performance data, meeting the criteria for an Annual Report (10-K). FY 2005
2006-04-27 German

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.